Skip to main content
. 2018 Aug;10(8):5086–5099. doi: 10.21037/jtd.2018.08.67

Table 3. Compared main indicators in male subgroup.

Research indicators Male subgroup
Underweight
BMI <18.5 (n=47)
Normal weight
18.5≤ BMI <25 (n=276)
Overweight
25≤ BMI <30 (n=163)
Obesity BMI ≥30 (n=87) P value
Main indicators of lung function
   FEV1 46.10 (29.80–63.90) 44.30 (32.43–62.98) 50.30 (34.50–69.80) 68.60 (52.80-78.30) <0.001
   FVC* 72.98 (35.10–104.90) 66.26 (24.30–125.80) 66.72 (33.00–98.80) 76.89 (36.10-113.40) <0.001
   PEF 34.30 (27.10–57.80) 40.15 (27.03–56.30) 49.90 (32.90–69.80) 65.40 (51.90-79.40) <0.001
   FEF25 18.60 (8.70–33.30) 18.15 (10.90–34.25) 26.80 (13.10–47.40) 29.70 (23.15-43.35) <0.001
   FEF50 14.45 (8.73–32.58) 15.30 (9.60–26.58) 20.30 (11.00–38.70) 33.70 (22.80-51.20) <0.001
   FEF75 24.30 (16.43–49.08) 22.85 (14.90–38.20) 25.10 (14.90–44.20) 44.45 (28.75-65.30) <0.001
   TLC 77.85 (66.28–93.63) 77.10 (64.05–87.40) 73.45 (63.20–86.60) 79.90 (69.10-86.90) 0.136
   RV 99.10 (77.63–141.13) 101.50 (80.48–128.65) 101.60 (74.43–127.38) 103.00 (83.30–118.90) 0.671
   DLCO* 40.79 (8.09–79.30) 45.61 (3.80–188.20) 53.36 (4.33–108.40) 72.20 (27.60–117.30) <0.001
   DLCO/VA* 47.52 (5.70–116.70) 56.32 (1.29–185.50) 71.61 (1.69–186.30) 97.03 (43.90–171.80) <0.001
PAP (by Doppler cardiac ultrasound) 34.00 (31.00-44.00) 34.00 (28.00–41.75) 34.50 (28.00–41.25) 32.00 (28.50–34.00) 0.252
Times of AECOPD in years 6.00 (2.50–8.75) 2.00 (1.00–4.00) 2.00 (1.00–5.75) 2.00 (1.00–5.75) 0.110
Moderate exacerbations in 3 years 1.00 (0.00–4.25) 0.00 (0.00–2.00) 0.00 (0.00–2.75) 1.00 (0.00–5.50) 0.257
Severe exacerbations in3 years 2.50 (1.00–5.25) 1.00 (1.00–2.00) 1.00 (1.00–1.75) 0.50 (0.00–1.00) 0.003
Frequency of AECOPD per year 2.00 (0.83–2.95) 0.70 (0.30–1.30) 0.70 (0.30–1.93) 0.70 (0.31–1.93) 0.080

Data presented as median (IQR) unless specified. *, data presented as mean (range). BMI, body mass index; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; PEF, peak expiratory flow; FEF, forced expiratory flow; TLC, total lung capacity; RV, residual volume; DLCO, diffusing capacity of carbon monoxide; DLCO/VA, ratio of carbon monoxide diffusion capacity to alveolar ventilation; PAP, pulmonary arterial pressure; AECOPD, acute exacerbation of chronic obstructive pulmonary disease.